Pfizer/BioNTech C4591001 Trial – Audit Report – v1 (2024-05-31): Reanalysis of the Data and Anomalies Inventoried
Abstract This review aims to address significant anomalies and discrepancies that have surfaced from the examination of the data from the Pfizer/BioNTech C4591001 trial, which could have profound implications for public trust and regulatory standards, should they not be adequately and transparently investigated. Whistleblower Testimonies Brook Jackson, a former regional director at Ventavia Research […]
Discuss on Nostr!
Nostr Note ID note1l396sgc6sslthzrs9cp49gqjdxyhya70smyymmlwtr7wue5ujaksy68w3w Open on Primal.net Open on Snort.social Open on Iris.to Open on Coracle.social
New to Nostr?
Create an account now & join the conversation!
Promote it on DissentWatch!
- To advertise this post for $0.02 per visit send bitcoins to the address below
- The post will be promoted daily via social media & our "Featured News" display in multiple places
- You can add more anytime
- Ranking order in the Featured News box is based on the balance remaining
Received: 0 mBTC (0.00 USD)
Spent: 0 mBTC (0.00 USD)
Balance: 0 mBTC (0.00 USD)
The amounts above may be lagging behind. If you just sent a payment click below to get more up to date results and push the post to the "Featured News" box faster.